TP53 and colorectal cancer: For our cyclotherapy approach, we used isogenic HCT116 colorectal cancer cell lines, HCT116+/+p53 with wild type p53 or HCT116−/−p53, which do not express full-length p53 but some of the identified p53 isoforms23.